Online Pet Medications & Pet Supplies


Category: C

Select Option
Product REF: ARCLA05
CLAVUDALE 200MG/50MG FLAV TAB 24PK - £ 20.40
Product REF: ARCLA06
CLAVUDALE 400MG/100MG FLAV TAB 24PK - £ 38.16
Product REF: ARCLA07
Product REF: ARCLA08
CLAVUDALE TABLETS 200MG 120PK - £ 118.34
Product REF: ARCLA09
CLAVUDALE TABLETS 400MG 120PK - £ 173.84
Product REF: ARCLA10

Total Price: £0.00

Vat Rate: 20%

Prescription Required

Target species Clavudale 40 mg/10 mg - Cats and dogs. Clavudale 200 mg/50 mg and 400 mg/100 mg - Dogs Indications for use For the treatment of bacterial infections susceptible to amoxicillin in combination with clavulanic acid where clinical experience and/or sensitivity testing indicates the product as the drug of choice. Uses include: Skin infections (including deep and superficial pyodermas) associated with Staphylococcus spp. and Streptococcus spp.; Infections of the oral cavity (mucous membrane) associated with Clostridium spp., Corynebacterium spp., Staphylococcus spp., Streptococcus spp., Bacteroides spp. and Pasteurella spp.; Urinary tract infections associated with Staphylococcus spp., Streptococcus spp., Escherichia coli and Proteus mirabilis; Respiratory tract infections associated with Staphylococcus spp., Streptococcus spp. and Pasteurella spp.; Gastrointestinal infections associated with Escherichia coli and Proteus mirabilis. Contraindications Do not use in rabbits, guinea pigs, hamsters and gerbils. Do not use in animals with known hypersensitivity to penicillin or substances of the β-lactam group or any of the excipients. Do not use in animals with either oliguria or anuria associated with renal dysfunction. Do not use in cases of known resistance to the combination of amoxicillin and clavulanic acid. Special precautions for use in animals Caution is advised on the use of the product in small herbivores other than those listed in Contraindications. In animals with hepatic and renal dysfunction, the dosing regimen should be carefully evaluated. Use of the product should be based on susceptibility testing and should take into account official national and regional policies with respect to the use of broad spectrum antibiotics. Do not use in cases of bacteria sensitive to narrow spectrum penicillins or to amoxicillin as a single substance. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to amoxicillin and clavulanic acid, and may decrease the effectiveness of treatment with other β-lactam antibiotics, due to the potential for cross-resistance. Special precautions to be taken by the person administering the veterinary medicinal product to animals Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. - Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. - Handle this product with great care to avoid exposure, taking all recommended precautions. - If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention. - Wash hands after use. Adverse reactions Mild gastrointestinal signs (diarrhoea and vomiting) may occur after administration of the product. Allergic reactions (skin reactions, anaphylaxis), blood dyscrasia and colitis may occasionally occur. In these cases, discontinue administration and give symptomatic treatment. Use during pregnancy and lactation Laboratory studies in rats and mice have not produced any evidence of teratogenic or foetotoxic effects. No studies have been conducted in pregnant or lactating dogs or cats. Use only according to the benefit/risk assessment by the responsible veterinarian. Interactions Bacteriostatic antibiotics (e.g. chloramphenicol, macrolides, sulfonamides and tetracyclines) may inhibit the antibacterial effects of penicillins. The potential for allergic cross-reactivity with other penicillins should be considered. Penicillins may increase the effect of aminoglycosides.

Our Standard Delivery - £6.75

Royal Mail Tracked 24 (Signed For)

  • Next business day service
  • Compensation cover up to £100
  • Signature on delivery


Any orders placed after close of business on Thursday will not be delivered until Tuesday




Our Express Delivery - £10.45

Royal Mail Special Delivery Guaranteed by 1pm

  • Next business day service
  • Insured up to £500
  • Signature on delivery


Please note that all chilled deliveries must be sent on an Express service.

Chilled orders placed after close of business on Wednesday will not be despatched until Monday

You must be logged in to write review
Category POM-V
Temperature Ambient
MA/VM/EU No: 10434/4052
  • cats
  • dogs
VMD Link
Dosage Amounts to be administered and administration route For oral administration only. The dosage rate is 10 mg amoxicillin/2.5 mg clavulanic acid/kg body weight twice daily. The tablets may be added to a little food. To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing. The following table is intended as a guide to dispensing the product at the standard dose rate of 10 mg amoxicillin/2.5 mg clavulanic acid/kg body weight twice daily. Clavudale 40 mg/10 mg tablets for cats and dogs - dosage table: Body weight (kg) Number of tablets twice daily 1 to ≤ 2 ½ > 2 to ≤ 4 1 > 4 to ≤ 6 1½ > 6 to ≤ 8 2 Clavudale 200 mg/50 mg tablets for dogs - dosage table: Body weight (kg) Number of tablets twice daily > 8 to ≤ 10 ½ > 10 to ≤ 20 1 > 20 to ≤ 30 1½ > 30 to ≤ 40 2 Clavudale 400 mg/100 mg tablets for dogs - dosage table: Body weight (kg) Number of tablets twice daily > 30 to ≤ 40 1 > 40 to ≤ 60 1½ > 60 to ≤ 80 2 In refractory cases the dose may be doubled to 20 mg amoxicillin/5 mg clavulanic acid/kg body weight twice daily. Duration of therapy: Routine cases involving all indications: The majority of routine cases respond to between 5 and 7 days of therapy. Lack of effect after 5 to 7 days of treatment necessitates renewed examination. Chronic or refractory cases: In chronic cases, longer courses of antibacterial therapy may be required. In such circumstances, overall treatment length is at the clinician’s discretion, but must be long enough to ensure complete resolution of the bacterial disease. Overdose Mild gastrointestinal symptoms (diarrhoea and vomiting) may occur more frequently after overdose of the product.